Noticias de REGN_US

Noticias del mercado

Últimas noticias sobre REGN_US — 563 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.

Ticker: REGN_US ✕ 563 resultados
29/04/2026 REGN_US — GuruFocus ES ← EN
Regeneron Pharmaceuticals (REGN) informa sólidas ganancias en el primer trimestre con anuncio de recompra de acciones

Regeneron Pharmaceuticals (REGN) Reports Strong Q1 Earnings with Share Buyback Announcement

29/04/2026 REGN_US — GuruFocus ES ← EN
Transcripción de la llamada de resultados del primer trimestre de 2026 de Regeneron Pharmaceuticals Inc

Q1 2026 Regeneron Pharmaceuticals Inc Earnings Call Transcript

29/04/2026 REGN_US — MarketScreener
Regeneron Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026
29/04/2026 REGN_US — GuruFocus ES ← EN
Regeneron Pharmaceuticals (REGN) informa sólidas ganancias en el primer trimestre con anuncio de recompra de acciones

Regeneron Pharmaceuticals (REGN) Reports Strong Q1 Earnings with Share Buyback Announcement

29/04/2026 REGN_US — GuruFocus ES ← EN
Regeneron (REGN) informa sólidos ingresos en el primer trimestre y una nueva iniciativa de fijación de precios de medicamentos

Regeneron (REGN) Reports Strong Q1 Revenue and New Drug Pricing Initiative

29/04/2026 REGN_US — MarketScreener ES ← EN
Ganancias ajustadas del primer trimestre de Regeneron Pharmaceuticals y aumento de ingresos

Regeneron Pharmaceuticals Q1 Adjusted Earnings, Revenue Rise

29/04/2026 REGN_US — GuruFocus ES ← EN
¿Regeneron (REGN) sigue infravalorado un 23,3% después del primer trimestre de 2026? No-G

Is Regeneron (REGN) Still 23.3% Undervalued After Q1 2026? Non-G

29/04/2026 REGN_US — Investing.com Nigeria ES ← EN
Regeneron supera las estimaciones del primer trimestre gracias a la fortaleza de Dupixent Por Investing.com

Regeneron beats first quarter estimates on Dupixent strength By Investing.com

29/04/2026 REGN_US — MarketScreener
Earnings Flash (REGN) Regeneron Pharmaceuticals, Inc. Posts Q1 Adjusted EPS $9.47 per Share, vs. FactSet Est of $8.91
29/04/2026 REGN_US — KTVB
Regeneron: Q1 Earnings Snapshot
29/04/2026 REGN_US — KVUE
Regeneron: Q1 Earnings Snapshot
29/04/2026 REGN_US — MarketScreener
Regeneron Pharmaceuticals, Inc. announces an Equity Buyback for $3,000 million worth of its shares.
29/04/2026 REGN_US — TradingKey
Regeneron Pharmaceuticals Inc Stock (REGN) Moved Down by 7.82% on Apr 29: Facts Behind the Movement
29/04/2026 REGN_US — Seeking Alpha
Regeneron Pharmaceuticals: Q1 Beat Driven By Dupixent And Eylea HD Strength (NASDAQ:REGN)
29/04/2026 REGN_US — MarketScreener
Tranche Update on Regeneron Pharmaceuticals, Inc.'s Equity Buyback Plan announced on February 4, 2025.
29/04/2026 REGN_US — MarketBeat
Certuity LLC Reduces Stock Position in Regeneron Pharmaceuticals, Inc. $REGN
29/04/2026 REGN_US — MarketBeat
Mitsubishi UFJ Trust & Banking Corp Decreases Stock Position in Regeneron Pharmaceuticals, Inc. $REGN
29/04/2026 REGN_US — Yahoo Finance
Regeneron Q1 Earnings Top, Sales Up on Dupixent & Eylea HD Strength
29/04/2026 REGN_US — Seeking Alpha
Regeneron Pharmaceuticals, Inc. 2026 Q1 - Results - Earnings Call Presentation (NASDAQ:REGN) 2026-04-29
29/04/2026 REGN_US — MarketBeat
Regeneron Pharmaceuticals Q1 Earnings Call Highlights

Página 19 de 29

keyboard_arrow_up